Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.
The company's new GLP-1 program will offer both oral and injectable medications ...
People taking GLP-1s had reduced risk for atrial fibrillation, regardless of whether they lost weight or how much they lost, ...